Company

Amount Raised


Biomet Inc. (August)

$1B

Salix Pharmaceuticals (March)

$690M

Elan Corp. plc (March)

$381M

Theravance Inc. (April)

$212.9M

Isis Pharmaceuticals Inc. (August)

$201.25M

Amarin Corp. plc (January)

$150M

Nektar Therapeutics Inc. (July)

$125M

Sequenom Inc. (September)

$110M

Vernalis plc (February)

$103.8M

ThromboGenics NV (March)

$103.2M